View Older Stories View More Recent Stories
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
LiquidX Names Dominic Capolongo as Chief Revenue Officer
-
LiquidX Names Dominic Capolongo as Chief Revenue Officer
-
Rio Tinto Plc. (RIO:LN) (RIO) PT Raised to GBP56 at RBC Capital
-
Chemtrade Launches Process to Sell Vancouver Real Estate Through a Sale-Leaseback Transaction
-
Bank of New York Mellon (BK) PT Lowered to $56 at RBC Capital
-
Vale S.A. (VALE) PT Raised to $20 at RBC Capital
-
RBC Capital Starts Guidewire (GWRE) at Outperform
-
Ara Partners Promotes Katy Boettcher to Principal and Adds Ken Nguyen as Senior Associate
-
Anglo Pacific Group PLC Announces Favourable Four Mile Legal Dispute Ruling
-
ELS Reports First Quarter Results
-
MHS and Fortna to Combine to Create Global eCommerce and Logistics Automation Leader
-
Soaring interest rates weigh on big bank mortgage loan growth
-
The Sterling Group Announces New Hires and Promotions
-
Service Properties Trust Announces Amendment to Credit Facility and Extends Maturity Date to January 2023
-
UnitedHealth Group (UNH) PT Raised to $588 at RBC Capital
-
Nurix (NRIX) PT Lowered to $39 at RBC Capital
-
GitLab Inc (GTLB) PT Raised to $64 at RBC Capital
-
RAPID GROWTH OF BUY NOW, PAY LATER (BNPL) INDUSTRY REVEALS CHALLENGES FOR CONSUMERS, LENDERS, AND REGULATORS
-
UPDATE: Edison International (EIX) PT Raised to $82 at RBC Capital on Wildfire Mitigation Efforts
-
UPDATE: RBC Capital Starts Verastem (VSTM) at Outperform
-
Orchid Island Capital Announces Estimated First Quarter 2022 Results, April 2022 Monthly Dividend and March 31, 2022 RMBS Portfolio Characteristics
-
Form MA-I RBC Capital Markets,
-
UPDATE: CarMax (KMX) Near Term Setup is Challenging, PT Lowered to $104 at RBC Capital
-
UPDATE: Meta Platforms Inc. (FB) is Facing Another Rocky Quarter, PT Lowered to $240 at RBC Capital
-
UPDATE: RBC Capital Starts Edgewise Therapeutics (EWTX) at Outperform
-
RIVERNORTH OPPORTUNITIES FUND, INC. PRICES OFFERING OF PREFERRED STOCK
-
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
-
UPDATE: Gilead Sciences (GILD) PT Raised to $77 at RBC Capital
-
Stryker (SYK) CMS Outpatient Code for InSpace Subacromial Balloon Spacer an 'Incremental Positive' - RBC
-
RBC Global Asset Management Launches China Equity Fund
-
CarParts.com (PRTS) Estimates Raised After Management Meeting - RBC Capital
-
Japanese investors remain big sellers of overseas bonds in March
-
Anglo Pacific Group PLC Announces Notice of 2022 Annual General Meeting
-
Sun Communities, Inc. Closes Acquisition of Park Holidays UK
-
Sun Communities, Inc. Closes Acquisition of Park Holidays UK
-
WonderFi Appoints Former Royal Bank of Canada Senior Counsel Adam Garetson as Chief Legal Officer
-
CarMax (KMX) Expectations Look Reasonable but Industry Data is Trending Down - RBC Capital
-
CrowdStrike Holdings (CRWD) Investor Day Outlines $7B Opportunity - RBC Capital
-
UPDATE: RBC Capital Starts Raytheon Technologies Corp. (RTX) at Outperform
-
UPDATE: RBC Capital Upgrades Gatos Silver (GATO) to Sector Perform
-
Australia's Graincorp raises profit view on Ukraine conflict-led shortage
-
U.S. Medicare limits coverage for Biogen's Alzheimer's drug
-
CDK Global (CDK) Acquired by Brookfield (BBU) for $54.87/sh or $8.3B
-
Brookfield to Acquire CDK Global Inc.
-
Brookfield to Acquire CDK Global Inc.
-
UPDATE: RBC Capital Upgrades Sylvamo Corp. (SLVM) to Outperform
-
UPDATE: RBC Capital Downgrades Rayonier Advanced Materials (RYAM) to Sector Perform

